S&P 500 Futures
(0.27%) 5 145.25 points
Dow Jones Futures
(0.27%) 38 546 points
Nasdaq Futures
(0.38%) 17 914 points
Oil
(-0.75%) $83.22
Gas
(1.35%) $1.949
Gold
(-0.17%) $2 343.10
Silver
(1.11%) $27.56
Platinum
(0.65%) $928.10
USD/EUR
(-0.26%) $0.932
USD/NOK
(-0.21%) $11.00
USD/GBP
(-0.36%) $0.798
USD/RUB
(0.87%) $92.68

Actualizaciones en tiempo real para Cyxone AB (publ) [CYXO.ST]

Bolsa: STO Sector: Healthcare Industria: Biotechnology
Última actualización26 abr 2024 @ 11:05

-4.33% SEK 0.0928

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 11:05):

Cyxone AB (publ), a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis, multiple sclerosis, and treatments for virally induced acute respiratory disorders...

Stats
Volumen de hoy 1.15M
Volumen promedio 739 347
Capitalización de mercado 9.14M
EPS SEK0 ( 2024-02-23 )
Próxima fecha de ganancias ( SEK0 ) 2024-05-10
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -0.220
ATR14 SEK0.00100 (1.08%)

Cyxone AB (publ) Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cyxone AB (publ) Finanzas

Annual 2023
Ingresos: SEK0
Beneficio Bruto: SEK-2.54M (0.00 %)
EPS: SEK-0.220
FY 2023
Ingresos: SEK0
Beneficio Bruto: SEK-2.54M (0.00 %)
EPS: SEK-0.220
FY 2022
Ingresos: SEK6.40M
Beneficio Bruto: SEK4.16M (64.98 %)
EPS: SEK-0.430
FY 2021
Ingresos: SEK0.00
Beneficio Bruto: SEK0.00 (0.00 %)
EPS: SEK-0.429

Financial Reports:

No articles found.

Cyxone AB (publ)

Cyxone AB (publ), a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis, multiple sclerosis, and treatments for virally induced acute respiratory disorders. Its development portfolio comprises Rabeximod in a clinical Phase II program for rheumatoid arthritis and Covid-19 infections; and T20K, a Phase 1 candidate drug for the treatment of multiple sclerosis. The company was incorporated in 2015 and is based in Malmö, Sweden.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico